McGill University Health Centre, Montreal, Quebec.
Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario.
J Clin Rheumatol. 2018 Aug;24(5):243-249. doi: 10.1097/RHU.0000000000000679.
Canadian rheumatologists' attitudes toward and management of fibromyalgia remain uncertain.
The aim of this study was to explore management strategies and attitudes of Canadian rheumatologists toward fibromyalgia and concordance with guideline recommendations.
We administered a 17-item cross-sectional survey to Canadian rheumatologists and explored the concordance between respondents' management practices with the 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia.
Among 331 Canadian rheumatologists who were approached, 140 returned the survey for a 42% response rate. The majority felt that fibromyalgia was a useful clinical diagnosis (110/138 [80%]) but was divided as to whether fibromyalgia was objectively defined (75/138 [54%]) or a psychosocial condition (42/138 [30%]) or could result in an inability to work (37/138 [27%]). Contrary to guideline recommendations, most (82/134 [61%]) endorsed that tender points were useful for diagnosis. Half endorsed potentially refusing consultations with fibromyalgia patients, and only 42% (59/139) agreed that there were effective therapies for this syndrome. Consistent with the guideline, most respondents managed fibromyalgia with education, exercise therapy, antidepressants, and nonnarcotic analgesics (≥89% for all); however, fewer than half agreed that any of these modalities were effective (endorsement ranged from 9% to 47%). Assessment of the 2012 guideline revealed a number of important limitations.
Canadian rheumatologists largely do not provide primary care for fibromyalgia. Most adhere to guideline recommendations for management of fibromyalgia, but few endorse these interventions as effective. Further research, including updating of the 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia, is required to inform this disconnect.
加拿大风湿病学家对纤维肌痛的态度和管理仍不确定。
本研究旨在探讨加拿大风湿病学家对纤维肌痛的管理策略和态度,以及与指南建议的一致性。
我们向加拿大风湿病学家发放了一份 17 项的横断面调查,探讨了受访者的管理实践与 2012 年加拿大纤维肌痛诊断和管理指南的一致性。
在 331 名被邀请的加拿大风湿病学家中,有 140 名返回了调查,应答率为 42%。大多数人认为纤维肌痛是一种有用的临床诊断(110/138[80%]),但对于纤维肌痛是否有客观定义(75/138[54%])或是否是一种心理社会状况(42/138[30%]),或者是否会导致无法工作(37/138[27%])存在分歧。与指南建议相反,大多数人(82/134[61%])认为压痛点对诊断有用。有一半人赞成可能拒绝与纤维肌痛患者会诊,只有 42%(59/139)同意该综合征有有效的治疗方法。与指南一致,大多数受访者通过教育、运动疗法、抗抑郁药和非麻醉性镇痛药来管理纤维肌痛(所有方法的应答率均为≥89%);然而,不到一半的人认为这些方法中的任何一种都有效(认同程度从 9%到 47%不等)。对 2012 年指南的评估显示了一些重要的局限性。
加拿大风湿病学家在很大程度上不提供纤维肌痛的初级保健。大多数人遵守纤维肌痛管理指南的建议,但很少有人认为这些干预措施有效。需要进一步研究,包括更新 2012 年加拿大纤维肌痛诊断和管理指南,以了解这种脱节的原因。